Rare diseases
Investigational molecules
Locations
Ul. Swobodna 38, 15-756 Bialystok, Poland
Revit Sp. z o.o. in Bialystok, Poland specialises in clinical trials of conditions such as Dementia Alzheimer's type, Chronic rhinosinusitis with nasal polyps, Back pain, Dementia of the Alzheimer's type uncomplicated, and other specialisations. This site conducts important research.
The Podlaskie Centrum Psychogeriatrii is investigating conditions such as Chronic Low Back Pain and metabolic factors that influence musculoskeletal health, aiming to improve pain management and functional outcomes.
At Revit Sp. z o.o., 10 clinical trials are active with 4 investigators, highlighting a strong commitment to advancing musculoskeletal care.
Research at the centre focuses on neurodegenerative conditions, including Alzheimer Disease and early‑stage Parkinson’s Disease, with the goal of slowing cognitive decline and preserving neurological function.
The site’s portfolio of 10 trials reflects a multidisciplinary effort to address the growing burden of nervous system disorders.
The clinic conducts studies on chronic inflammatory airway conditions, notably Chronic Rhinosinusitis with Nasal Polyps, to assess new treatments that reduce polyp size and improve nasal airflow.
These efforts are part of the broader research agenda of Revit Sp. z o.o., contributing to better respiratory health outcomes.
Clinical investigations include patients with Schizophrenia who have experienced cognitive impairment, seeking to gather safety data and explore adjunctive treatments that support cognition.
The department’s focus on mental health aligns with its mission to improve psychiatric care through evidence‑based research.
Beyond disease‑specific studies, the centre addresses broader health challenges such as Obesity and metabolic risk factors, integrating insights from neurology, psychiatry, and musculoskeletal science.
With a total of 10 trials and a dedicated team of 4 investigators, Revit Sp. z o.o. exemplifies a collaborative approach to complex health issues.
Clinical trials currently enrolling participants at this site.
Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
PolandStudy of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks
PolandA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
PolandPolandStudy on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
PolandStudy on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia
PolandStudy on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy
PolandStudy of Retatrutide for Patients with Obesity, Overweight, and Chronic Low Back Pain
PolandStudy on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps
PolandStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
PolandLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
PolandStudy on Bepranemab for Patients with Early Alzheimer's Disease
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
